ValorQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26TTMFluxo de caixa de investimento0-162.46 M-39.54 M15.41 M34.98 M42 M52.85 MFluxo de caixa de financiamento3.81 M1 M19.65 M749 K245.87 M5.31 M271.58 MFluxo de caixa livre-25.35 M-29.42 M-29.6 M-29.57 M-42.98 M-42.63 M-144.77 M
Definium Therapeutics, Inc. - Common Shares
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.